Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2026-01-14 @ 11:32 AM
Study NCT ID:
NCT06640361
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2024-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Olverembatinib in SDH-deficient GIST.
Sponsor:
Ascentage Pharma Group Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HQP1351GG301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |